DK43991D0 - Allele varianter af plasmodium falciparum merozoitoverfladeantigen - Google Patents
Allele varianter af plasmodium falciparum merozoitoverfladeantigenInfo
- Publication number
- DK43991D0 DK43991D0 DK91439A DK43991A DK43991D0 DK 43991 D0 DK43991 D0 DK 43991D0 DK 91439 A DK91439 A DK 91439A DK 43991 A DK43991 A DK 43991A DK 43991 D0 DK43991 D0 DK 43991D0
- Authority
- DK
- Denmark
- Prior art keywords
- terminal
- surface antigen
- plasmodium falciparum
- sequences
- plasts
- Prior art date
Links
- 241000223960 Plasmodium falciparum Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 210000003936 merozoite Anatomy 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 210000004899 c-terminal region Anatomy 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- APCLRHPWFCQIMG-UHFFFAOYSA-N 4-(5,6-dimethoxy-1-benzothiophen-2-yl)-4-oxobutanoic acid Chemical compound C1=C(OC)C(OC)=CC2=C1SC(C(=O)CCC(O)=O)=C2 APCLRHPWFCQIMG-UHFFFAOYSA-N 0.000 abstract 1
- 101710203310 Apical membrane antigen 1 Proteins 0.000 abstract 1
- 101150092365 MSA2 gene Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 abstract 1
- 101100240989 Schizosaccharomyces pombe (strain 972 / ATCC 24843) nrd1 gene Proteins 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000004897 n-terminal region Anatomy 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
- C12N9/1088—Glutathione transferase (2.5.1.18)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPJ038288 | 1988-09-12 | ||
| AUPJ596289 | 1989-08-24 | ||
| PCT/AU1989/000388 WO1990002752A1 (en) | 1988-09-12 | 1989-09-12 | Allelic variants of plasmodium falciparum merozoite surface antigen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK43991D0 true DK43991D0 (da) | 1991-03-12 |
| DK43991A DK43991A (da) | 1991-05-08 |
Family
ID=25643542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK043991A DK43991A (da) | 1988-09-12 | 1991-03-12 | Allele varianter af plasmodium falciparum merozoitoverfladeantigen |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0433378B1 (da) |
| JP (1) | JPH04500668A (da) |
| KR (1) | KR900701831A (da) |
| AT (1) | ATE129504T1 (da) |
| DE (1) | DE68924649D1 (da) |
| DK (1) | DK43991A (da) |
| IL (1) | IL91609A0 (da) |
| WO (1) | WO1990002752A1 (da) |
| ZA (1) | ZA896942B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0434751A1 (en) * | 1988-09-16 | 1991-07-03 | Statens Seruminstitut | A malaria antigen |
| US20030161840A1 (en) | 1992-10-19 | 2003-08-28 | Institut Pasteur | Plasmodium falciparum antigens inducing protective antibodies |
| FR2697022B1 (fr) | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4767622A (en) * | 1983-08-19 | 1988-08-30 | University Of Illinois | Method and materials for development of immunological responses protective against malarial infection |
| JPS61107292A (ja) * | 1984-10-30 | 1986-05-26 | 株式会社東芝 | 出力装置 |
| AU595056B2 (en) * | 1986-07-17 | 1990-03-22 | Program For Appropriate Technology In Health (Path) | Merozoite surface antigen of plasmodium falciparum |
-
1989
- 1989-09-12 EP EP89910586A patent/EP0433378B1/en not_active Expired - Lifetime
- 1989-09-12 WO PCT/AU1989/000388 patent/WO1990002752A1/en active IP Right Grant
- 1989-09-12 JP JP1509913A patent/JPH04500668A/ja active Pending
- 1989-09-12 IL IL91609A patent/IL91609A0/xx unknown
- 1989-09-12 ZA ZA896942A patent/ZA896942B/xx unknown
- 1989-09-12 AT AT89910586T patent/ATE129504T1/de not_active IP Right Cessation
- 1989-09-12 DE DE68924649T patent/DE68924649D1/de not_active Expired - Lifetime
-
1990
- 1990-05-12 KR KR1019900700996A patent/KR900701831A/ko not_active Application Discontinuation
-
1991
- 1991-03-12 DK DK043991A patent/DK43991A/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA896942B (en) | 1990-08-29 |
| JPH04500668A (ja) | 1992-02-06 |
| DE68924649D1 (de) | 1995-11-30 |
| EP0433378A4 (en) | 1991-11-06 |
| ATE129504T1 (de) | 1995-11-15 |
| EP0433378B1 (en) | 1995-10-25 |
| WO1990002752A1 (en) | 1990-03-22 |
| EP0433378A1 (en) | 1991-06-26 |
| KR900701831A (ko) | 1990-12-04 |
| DK43991A (da) | 1991-05-08 |
| IL91609A0 (en) | 1990-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0423302T3 (da) | Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner | |
| PT100781A (pt) | Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas | |
| DE68924162D1 (de) | Stressproteine und verwendungen dafür. | |
| DE69829668D1 (de) | Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe | |
| DE3588254D1 (de) | Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen | |
| DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
| ATE263836T1 (de) | Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür | |
| ATE171710T1 (de) | Hcv peptidantigene und verfahren zur bestimmung von hcv | |
| NO910279D0 (no) | Eimeria overflateantigen samt coccidiosevaksine inneholdende slike. | |
| DK0594771T3 (da) | Cycloheximidresistens i nukleotidsekvenser og -proteiner | |
| DK43991D0 (da) | Allele varianter af plasmodium falciparum merozoitoverfladeantigen | |
| SE8801723D0 (sv) | Fibronectin binding protein as well as its preparation | |
| GB2244273A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. | |
| ATE71534T1 (de) | Vakzine. | |
| MY106940A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. | |
| AU660437B2 (en) | Protective plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens HRPII and SERP, the preparation and use thereof | |
| DE69928947D1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| ATE201046T1 (de) | Polypeptide und dafür kodierende dns, die mit humanen malariaparasiten assoziiert sind | |
| ATE143373T1 (de) | Proteine, vakzine und nucleinsäuren | |
| WO1994025594A3 (en) | Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii |